>
The Decline Of Boys Participating In Youth Sports Has Led To A Generation Of Soft...
First Arrests Hint At How Billions In California Homeless Dollars Vanished...
Trump Refiles $15 Billion Defamation Lawsuit Against New York Times After Court Dismissal
Can Diet-Changes Really Transform ADHD? One Family's Remarkable Discovery
3D Printed Aluminum Alloy Sets Strength Record on Path to Lighter Aircraft Systems
Big Brother just got an upgrade.
SEMI-NEWS/SEMI-SATIRE: October 12, 2025 Edition
Stem Cell Breakthrough for People with Parkinson's
Linux Will Work For You. Time to Dump Windows 10. And Don't Bother with Windows 11
XAI Using $18 Billion to Get 300,000 More Nvidia B200 Chips
Immortal Monkeys? Not Quite, But Scientists Just Reversed Aging With 'Super' Stem Cells
ICE To Buy Tool That Tracks Locations Of Hundreds Of Millions Of Phones Every Day
Yixiang 16kWh Battery For $1,920!? New Design!
Find a COMPATIBLE Linux Computer for $200+: Roadmap to Linux. Part 1
Unapproved FDA anti-psychotics prescription drugs have been prescribed for two-year-olds who supposedly have bipolar disorder. On the record with Johnson and Johnson internal documents that have been uprooted, a certain doctor, who happens to be the chief of pediatric psychopharmacology at Harvard's Massachusetts General Hospital, appears to have pushed these unapproved drugs through speaking engagement fees for over $1.6 million, for a period of seven years, several years back.
One Joseph L. Biederman, with deep (filled) pockets and extensive ties to J&J, is a consultant who may be guilty of pushing psychotropic drugs that are prescribed for toddlers who go from crying to happy, and back to crying, too much. Isn't that just called the "terrible twos?" Since when do 2-year olds need toxic drugs that give them thoughts of suicide because they're moody?